Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
263
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
+331K
-
Total reported value, excl. options
-
$2.64B
-
Value change
-
-$56M
-
Put/Call ratio
-
1.48
-
Number of buys
-
133
-
Number of sells
-
-171
-
Price
-
$105.12
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2022
358 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 263 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 33M outstanding shares and own 76.01% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.03M shares), WELLINGTON MANAGEMENT GROUP LLP (2.44M shares), JPMORGAN CHASE & CO (1.69M shares), RIVERBRIDGE PARTNERS LLC (1.5M shares), AMERIPRISE FINANCIAL INC (1.18M shares), STATE STREET CORP (852K shares), PRICE T ROWE ASSOCIATES INC /MD/ (746K shares), Bank of New York Mellon Corp (597K shares), Bellevue Group AG (585K shares), and Ensign Peak Advisors, Inc (573K shares).
This table shows the top 263 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.